Study to Evaluate the Immunogenicity and Safety of LBVD (Hexavalent Vaccine; DTwP-HepB-IPV-Hib Vaccine), Given to Healthy Infants at Primary Series

Conditions:   Diphtheria;   Tetanus;   Pertussis;   Hepatitis B;   Poliomyelitis;   Haemophilus Influenzae Type B Infection Interventions:   Biological: LBVD (Hexavalent vaccine);   Biological: Pentavalent vaccine and Inactivated Polio vaccine (Sabin strains) Sponsor:   LG Chem Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials